Table 4.
Descriptive statistics of levels of spontaneous and chewing pain during 0.016*0.022 NiTi and 0.017*0.025 NiTi archwires in the three groups along with p-values of significance testing.
| 0.016*0.022 inch NiTi archwire | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time | Group | N | Spontaneous pain | Chewing pain | ||||||
| Mean (SD) | P-value* | Pairwise comparisons § | Mean (SD) | P-value* | Pairwise comparisons§ | |||||
| Pair | P-value† | Pair | P-value† | |||||||
| h0 | Laser | 17 | 0.7 (0.8) | 0.327 | 0.9 (0.9) | 0.550 | ||||
| Drug | 17 | 1.1 (0.8) | 1.2 (1.2) | |||||||
| Control | 18 | 1.5 (2.0) | 1.8 (2.1) | |||||||
| 1 h | Laser | 17 | 1.4 (1.6) | 0.188 | 1.8 (1.6) | 0.177 | ||||
| Drug | 17 | 1.2 (0.9) | 1.8 (1.1) | |||||||
| Control | 18 | 2.4 (2.3) | 3.2 (2.7) | |||||||
| 24 h | Laser | 17 | 2.2 (2.5) | 0.017 | Laser vs. Drug | 0.245 | 3.1 (2.7) | 0.033 | Laser vs. Drug | 0.231 |
| Drug | 17 | 1.1 (0.9) | Laser vs. Control | 0.003 | 1.9 (1.2) | Laser vs. Control | 0.007 | |||
| Control | 18 | 3.1 (2.2) | Drug vs. Control | 0.184 | 3.8 (2.2) | Drug vs. Control | 0.273 | |||
| 48 h | Laser | 17 | 2.0 (2.6) | 0.003 | Laser vs. Drug | 0.045 | 2.7 (3) | 0.010 | Laser vs. Drug | 0.150 |
| Drug | 17 | 0.5 (0.8) | Laser vs. Control | 0.001 | 1.1 (1.1) | Laser vs. Control | 0.001 | |||
| Control | 18 | 2.7 (2.4) | Drug vs. Control | 0.207 | 3.4 (2.4) | Drug vs. Control | 0.232 | |||
| 1 week | Laser | 17 | 0.9 (1.2) | 0.349 | 1.8 (1.6) | 0.254 | ||||
| Drug | 17 | 0.4 (0.6) | 0.9 (1.2) | |||||||
| Control | 18 | 1.1 (1.9) | 1.8 (2.2) | |||||||
| Next visit | Laser | 17 | 0.0 (0.0) | 0.130 | 0.2 (0.4) | 0.486 | ||||
| Drug | 17 | 0.2 (0.4) | 0.4 (0.6) | |||||||
| Control | 18 | 0.8 (1.5) | 0.8 (1.8) | |||||||
| 0.017*0.025 inch NiTi archwire | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time | Group | N | Spontaneous pain | Chewing pain | ||||||
| Mean (SD) | P-value* | Pairwise comparisons § | Mean (SD) | P-value* | Pairwise comparisons§ | |||||
| Pair | P-value† | Pair | P-value† | |||||||
| h0 | Laser | 17 | 0.4 (0.5) | 0.161 | 0.6 (0.9) | 0.183 | ||||
| Drug | 17 | 0.9 (1) | 0.9 (1.4) | |||||||
| Control | 17 | 1.2 (1.6) | 1.6 (1.8) | |||||||
| 1 h | Laser | 17 | 0.4 (1) | 0.150 | 0.8 (1) | 0.140 | ||||
| Drug | 17 | 0.9 (1) | 1.2 (1.3) | |||||||
| Control | 17 | 1.7 (1.8) | 2.1 (1.4) | |||||||
| 24 h | Laser | 17 | 0.6 (1.1) | 0.017 | Laser vs. Drug | 0.131 | 0.8 (1.1) | 0.004 | Laser vs. Drug | 0.357 |
| Drug | 17 | 1.3 (1.4) | Laser vs. Control | 0.005 | 1.5 (1.9) | Laser vs. Control | 0.001 | |||
| Control | 17 | 1.9 (1.6) | Drug vs. Control | 0.259 | 2.4 (1.3) | Drug vs. Control | 0.038 | |||
| 48 h | Laser | 17 | 0.4 (0.8) | 0.006 | Laser vs. Drug | 1 | 0.8 (1.2) | 0.009 | Laser vs. Drug | 0.634 |
| Drug | 17 | 0.4 (0.6) | Laser vs. Control | 0.013 | 0.5 (0.8) | Laser vs. Control | 0.005 | |||
| Control | 17 | 1.3 (1.4) | Drug vs. Control | 0.120 | 1.9 (1.5) | Drug vs. Control | 0.038 | |||
| 1 week | Laser | 17 | 0.4 (0.9) | 0.106 | 0.6 (0.9) | 0.170 | ||||
| Drug | 17 | 0.1 (0.3) | 0.2 (0.4) | |||||||
| Control | 17 | 0.8 (1.6) | 1.1 (1.3) | |||||||
| Next visit | Laser | 17 | 0.0 (0) | 0.364 | 0.0 (0) | 0.151 | ||||
| Drug | 17 | 0.1 (0.2) | 0.1 (0.2) | |||||||
| Control | 17 | 0.2 (0.5) | 0.2 (0.6) | |||||||
* Kruskal-Wallis test was applied; †: Mann-Whitney U test was used for pairwise comparisons; §: pairwise comparisons were applied when a significant difference was found between the groups in general; level of significance was set at 0.05 and Bonferroni’s correction was applied for post-hoc tests (i.e., adjusted α = 0.016); N: number of patients; h0: immediately after activation.